Notably, the in situ interaction of NPSARS-CoV-2 with G3BPs was observed in the lungs of patients with COVID-19 with the S protein of SARS-CoV-2 and G3BP1 (or G3BP2) as a control (Fig. 2C and D). This evidence concerns the gene G3BP2 and COVID-19.